{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:15:58Z","timestamp":1789917358172,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T00:00:00Z","timestamp":1409184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Brasileira de Reumatologia"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.rbr.2014.07.001","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:25:25Z","timestamp":1409099125000},"page":"452-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["N\u2010acetilciste\u00edna oral no tratamento do fen\u00f4meno de Raynaud secund\u00e1rio \u00e0 esclerose sist\u00eamica: ensaio cl\u00ednico randomizado, placebo\u2010controlado e duplo\u2010cego"],"prefix":"10.1186","volume":"54","author":[{"given":"Marcelo Jos\u00e9 Uchoa","family":"Correa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Ata\u00edde","family":"Mariz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Eduardo Coelho","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.rbr.2014.07.001_bib0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/rheumatology\/keh552","article-title":"Pathogenesis of Raynaud's phenomenon","volume":"44","author":"Herrick","year":"2005","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.rbr.2014.07.001_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-120-3-199402010-00004","article-title":"Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo\u2010controlled, double\u2010blind study","volume":"120","author":"Wigley","year":"1994","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.rbr.2014.07.001_bib0015","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8","article-title":"Calcium\u2010channel blockers for Raynaud's phenomenon in systemic sclerosis","volume":"44","author":"Thompson","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rbr.2014.07.001_bib0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","article-title":"EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)","volume":"68","author":"Kowal-Bielecka","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.rbr.2014.07.001_bib0025","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1590\/S0482-50042013000300004","article-title":"Recommendations for the management and treatment of systemic sclerosis","volume":"53","author":"Sampaio-Barros","year":"2013","journal-title":"Rev Bras Reumatol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0030","first-page":"4","article-title":"The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis","volume":"19","author":"Herrick","year":"2001","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0035","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/ard.2006.067504","article-title":"Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis","volume":"66","author":"Servettaz","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.rbr.2014.07.001_bib0040","first-page":"33","article-title":"Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis","volume":"45Suppl3","author":"Sunderk\u00f6tter","year":"2006","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.rbr.2014.07.001_bib0045","first-page":"114","article-title":"Clinical applications of N\u2010acetylcysteine","volume":"3","author":"Kelly","year":"1998","journal-title":"Altern Med Rev."},{"key":"10.1016\/j.rbr.2014.07.001_bib0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0735-1097(00)01093-7","article-title":"N\u2010acetylcysteine improves coronary and peripheral vascular function","volume":"37","author":"Andrews","year":"2001","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.ASN.0000107562.68920.92","article-title":"N\u2010acetylcysteine in the prevention of radiocontrast\u2010induced nephropathy","volume":"15","author":"Fishbane","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0060","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2143\/AC.62.6.2024017","article-title":"Effects of folic acid and N\u2010acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease","volume":"62","author":"Yilmaz","year":"2007","journal-title":"Acta Cardiol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000106103","article-title":"Effect of N\u2010acetylcysteine on endothelial dysfunction in dialysis patients","volume":"25","author":"Sahin","year":"2007","journal-title":"Blood Purif."},{"key":"10.1016\/j.rbr.2014.07.001_bib0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/clc.4960240719","article-title":"N\u2010acetylcysteine improves microcirculatory flow during smoking: new effects of an old drug with possible benefits for smokers","volume":"24","author":"Lu","year":"2001","journal-title":"Clin Cardiol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0075","first-page":"2257","article-title":"Intravenous N\u2010acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study","volume":"28","author":"Sambo","year":"2001","journal-title":"J Rheumatol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0080","doi-asserted-by":"crossref","first-page":"7761","DOI":"10.1177\/039463200501800420","article-title":"Significant changes of peripheral perfusion and plasma adrenomedullin levels in N\u2010acetylcysteine long term treatment of patients with sclerodermic Raynaud's phenomenon","volume":"18","author":"Salsano","year":"2005","journal-title":"Int J Immunopathol Pharmacol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0085","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s10067-009-1251-7","article-title":"The treatment with N\u2010acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients","volume":"28","author":"Rosato","year":"2009","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0090","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/ard.38.4.356","article-title":"Measurement of clinical change in progressive systemic sclerosis: a 1 year double\u2010blind placebo\u2010controlled trial of N\u2010acetylcysteine","volume":"38","author":"Furst","year":"1979","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.rbr.2014.07.001_bib0095","doi-asserted-by":"crossref","unstructured":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581\u201090.","DOI":"10.1002\/art.1780230510"},{"key":"10.1016\/j.rbr.2014.07.001_bib0100","first-page":"1573","article-title":"Criteria for the Classification of Early Systemic Sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0105","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1186\/ar3112","article-title":"Comparison of laser Doppler imaging, fingertip lacticemy test, and nailfold capillaroscopy for assessment of digital microcirculation in systemic sclerosis","volume":"12","author":"Correa","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.rbr.2014.07.001_bib0110","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1529-0131(199804)41:4<670::AID-ART14>3.0.CO;2-I","article-title":"Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: multicenter, placebo\u2010controlled, double\u2010blind study","volume":"41","author":"Wigley","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rbr.2014.07.001_bib0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.rdc.2007.11.006","article-title":"Diagnosis and management of scleroderma peripheral vascular disease","volume":"34","author":"Herrick","year":"2008","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.rbr.2014.07.001_bib0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.autrev.2005.08.004","article-title":"Digital ulcers in patients with systemic sclerosis","volume":"5","author":"Chung","year":"2006","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.rbr.2014.07.001_bib0125","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.rbr.2014.07.001_bib0130","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rbr.2014.07.001_bib0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/rheumatology\/38.4.309","article-title":"Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon","volume":"38","author":"Denton","year":"1999","journal-title":"Rheumatology."},{"key":"10.1016\/j.rbr.2014.07.001_bib0140","first-page":"349","article-title":"A double\u2010blind placebo\u2010controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis","volume":"18","author":"Herrick","year":"2000","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0145","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMoa042976","article-title":"High\u2010dose acetylcysteine in idiopathic pulmonary fibrosis","volume":"353","author":"Demdts","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rbr.2014.07.001_bib0150","first-page":"148","article-title":"Relato de caso","volume":"46","author":"Kayser","year":"2006","journal-title":"Tratamento de pacientes com \u00falceras isqu\u00eamicas secund\u00e1rias \u00e0 esclerose sist\u00eamica com N\u2010acetilciste\u00edna endovenosa. Rev Bras Reumatol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01061422","article-title":"Pharmacokinetics and bioavailability of reduced and oxidized N\u2010acetylcysteine","volume":"34","author":"Olsson","year":"1988","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0160","first-page":"1557","article-title":"Efficacy of oral N\u2010acetylcysteine in the treatment of acetaminophen overdose","volume":"319","author":"Smilkstein","year":"1988","journal-title":"Analysis of the national multicenter study (1976 to 1985). N Engl J Med."},{"key":"10.1016\/j.rbr.2014.07.001_bib0165","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.rbr.2014.07.001_bib0170","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0889-857X(03)00019-X","article-title":"Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma","volume":"29","author":"Hummers","year":"2003","journal-title":"Rheum Dis Clin North Am."},{"key":"10.1016\/j.rbr.2014.07.001_bib0175","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/rheumatology\/37.9.952","article-title":"Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo\u2010controlled, dose\u2010comparison study","volume":"37","author":"Black","year":"1998","journal-title":"Br J Rheumatol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0180","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.3899\/jrheum.090270","article-title":"Randomized placebo\u2010controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis","volume":"36","author":"Schiopu","year":"2009","journal-title":"J Rheumatol."},{"key":"10.1016\/j.rbr.2014.07.001_bib0185","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/art.24645","article-title":"Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders","volume":"61","author":"Murray","year":"2009","journal-title":"Arthritis Rheum."}],"container-title":["Revista Brasileira de Reumatologia"],"original-title":[],"language":"pt","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S048250041400151X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S048250041400151X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T06:03:31Z","timestamp":1565762611000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S048250041400151X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S048250041400151X"],"URL":"https:\/\/doi.org\/10.1016\/j.rbr.2014.07.001","relation":{},"ISSN":["0482-5004"],"issn-type":[{"value":"0482-5004","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u2010acetilciste\u00edna oral no tratamento do fen\u00f4meno de Raynaud secund\u00e1rio \u00e0 esclerose sist\u00eamica: ensaio cl\u00ednico randomizado, placebo\u2010controlado e duplo\u2010cego","name":"articletitle","label":"Article Title"},{"value":"Revista Brasileira de Reumatologia","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.rbr.2014.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}